ReviewFrontiers in nutrition2026
Milk fat globule membrane in early-life nutrition: composition, production, and biological effects on infant immune maturation, intestinal development, neurocognitive function, and growth.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The milk fat globule membrane (MFGM) is a trilayered structure encasing fat globules in mammalian milk, primarily composed of phospholipids, glycoproteins, and bioactive molecules. Recent research indicates that MFGM plays a fundamental role in early-life health, particularly through its effects on gut microbiota development and immune system maturation. In the initial months of life, the infant's gut microbiome undergoes rapid colonization, essential for immunological tolerance, metabolic programming, and pathogen defense. Numerous studies have shown that MFGM components, including sphingomyelin, gangliosides, and glycoproteins, exhibit prebiotic-like effects by facilitating the proliferation of beneficial bacteria, such as
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.